NR1H4 and Hepatic fibrosis: We believe that with the continuous advancement in research technologies, optimization of research methods, and enhancement of research mechanisms, it might be possible to target the gut microbiota–bile acid axis with the aim of delaying or even reversing liver fibrosis via the use of specific foods, antibiotics, probiotics, prebiotics, and bile acid receptor agonists.